Andon Health Company Limited operates within the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Andon Health Company Limited with three other companies in this sector in China: Jiangxi Sanxin Medtec Co Ltd (2018 sales of 531.30 million Chinese Renmimbi [US$75.52 million] of which 100% was Medical Equipment), Guangzhou Improve Medical Instruments Company Limited (549.96 million Chinese Renmimbi [US$78.18 million] of which 94% was Medical Industry), and Beijing Bohui Innovation Biotechnology Co Ltd (622.09 million Chinese Renmimbi [US$88.43 million] of which 53% was Blood Product).

Sales Analysis. During the year ended December of 2018, sales at Andon Health Company Limited were 563.88 million Chinese Renmimbi (US$80.16 million). This is a decrease of 5.7% versus 2017, when the company's sales were 597.92 million Chinese Renmimbi. Contributing to the drop in overall sales was the 6.2% decline in Medica Instruments, from 586.83 million Chinese Renmimbi to 550.38 million Chinese Renmimbi. . However, these declines were partially offset by the increase in sales of Others (up 21.8% to 13.50 million Chinese Renmimbi) .